I'm too busy trying to educate the stupid FRX reps that are calling on me to respond to amateur like yourself. Lets see, I unloaded all my FRX stock to buy SEPR at 6 & change and now SEPR is trading north of $45...now do the math and ask yourself: WHO IS THE MORON?
As for FRX...like I said before they are a good company, but the EASY MONEY have been made. Look at SGP and how generic Claritin devasted their top and bottom line. Generic Celexa will kill FRX's growth this summer. The SSRI market is huge, unlike the dementia market (too many physicians aren't treating). Namenda will not makeup the short fall in revenue growth. IMO also, FRX reps are clueless when it comes to selling...they like to bring donuts and lattes and think that it will sell their drugs. The guy who carried Namenda in his bag didn't even know how much it cost. It might work for the SSRI market, but not dementia or cardiovascular market. There's a new FRX rep calling on me every 5-6 months...the company keeps promotting reps that are not ready to be managers. They haven't even developed the sale skills yet, so how are they going to manage others. This will hurt FRX going forward with such inexperienced & unproven mgmt. The top reps that i've encountered are the reps from AZN, NVS and Sankyo. Those guys know how to sell...where as FRX reps are a dime a dozen.
Take it for what it's worth, but LLY and AZN are the top big pharma to own due to their pipeline.
ok amateur...hang around for your 4-5% return on FRX. Today is your lucky day...i'm going to give you 2 gems that will explode in the next year: DNDN & CVTX
I'll come back and look for you in a year or so and compare DNDN & CVTX to your FRX. FRX made me a bunch of money from the time i bought it during the Warner Lambert co-promote days with FRX...but it is DEAD money...